Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Standard Therapy as a Controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of HLCM051(MultiStem) in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by Pneumonitis

NCT03807804 is registered in ClinicalTrials.gov with Healios K.K. as lead sponsor.

NCT NCT03807804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03807804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Standard Therapy as a Controlled, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of HLCM051(MultiStem) in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by Pneumonitis
Lead sponsor
Healios K.K.
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2019
Completion date
December 14, 2021
Enrollment
35 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory distress syndrome, adult